State Street Corp lifted its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 0.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,686,993 shares of the company’s stock after acquiring an additional 6,398 shares during the period. State Street Corp owned 3.45% of Azenta worth $81,718,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its holdings in Azenta by 16.5% in the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its stake in Azenta by 1.9% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock valued at $278,783,000 after buying an additional 100,826 shares during the last quarter. Squarepoint Ops LLC boosted its holdings in Azenta by 433.6% in the second quarter. Squarepoint Ops LLC now owns 73,055 shares of the company’s stock worth $3,844,000 after acquiring an additional 59,364 shares in the last quarter. Finally, Royce & Associates LP grew its stake in shares of Azenta by 7.8% during the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock worth $35,844,000 after acquiring an additional 53,584 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.
Azenta Trading Down 1.0 %
Shares of NASDAQ:AZTA opened at $44.49 on Tuesday. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16. The company has a market cap of $2.03 billion, a PE ratio of -14.98 and a beta of 1.49. The company’s 50 day moving average is $44.47 and its 200 day moving average is $49.48.
Analysts Set New Price Targets
Several equities analysts recently commented on AZTA shares. Needham & Company LLC decreased their price objective on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Evercore ISI cut their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $63.60.
Check Out Our Latest Research Report on Azenta
Insider Activity
In other news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the sale, the chief financial officer now directly owns 24,604 shares in the company, valued at $1,074,702.72. This trade represents a 6.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John Marotta purchased 12,717 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was acquired at an average price of $39.48 per share, with a total value of $502,067.16. Following the purchase, the chief executive officer now owns 99,612 shares in the company, valued at $3,932,681.76. This represents a 14.63 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 3,018 shares of company stock valued at $126,689 in the last quarter. 1.77% of the stock is currently owned by company insiders.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- What is a Low P/E Ratio and What Does it Tell Investors?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- What is a Stock Market Index and How Do You Use Them?
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.